Suppr超能文献

通过靶向CPEB2鉴定微小RNA 885-5p作为结直肠癌肿瘤转移的新型调节因子

Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer.

作者信息

Lam Colin Siu-Chi, Ng Lui, Chow Ariel Ka-Man, Wan Timothy Ming-Hun, Yau Simon, Cheng Nathan Shiu-Man, Wong Sunny Kit-Man, Man Johnny Hon-Wai, Lo Oswens Siu-Hung, Foo Dominic Chi-Chung, Poon Jensen Tung-Chung, Pang Roberta Wen-Chi, Law Wai-Lun

机构信息

Division of Colorectal Surgery, Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

Centre for Cancer Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

出版信息

Oncotarget. 2017 Apr 18;8(16):26858-26870. doi: 10.18632/oncotarget.15844.

Abstract

Colorectal cancer is the third most common cancer in the world and liver is the most frequent site of distant metastasis with poor prognosis. The aim of this study is to investigate microRNAs leading to liver metastasis. We applied microarray analysis and quantitative PCR to identify and validate dysregulated miRNAs in liver metastases when compared to primary CRCs. Functional significance and the underlying molecular mechanism of selected miRNA was demonstrated by a series of in vitro and in vivo assays. Our microarray analysis and subsequent quantitative PCR validation revealed that miR-885-5p was strongly up-regulated in liver metastases and in CRC cell-lines derived from distant metastases. Overexpression of miR-885-5p significantly induced cell migration, cell invasion, formation of stress fibre in vitro and development of liver and lung metastases in vivo. MiR-885-5p induced metastatic potential of CRC by repressing cytoplasmic polyadenylation element binding protein 2 transcription through directly binding to two binding sites on its 3' untranslated region, and consequently led to up-regulation of TWIST1 and hence epithelial-mesenchymal transition. Our findings demonstrated the overexpression of miR-885-5p in liver metastasis and its roles in inducing CRC metastasis, potentiating development of miR-885-5p inhibitor to treat advanced CRC in the future.

摘要

结直肠癌是全球第三大常见癌症,肝脏是远处转移最常见的部位,预后较差。本研究的目的是调查导致肝转移的微小RNA。我们应用微阵列分析和定量PCR来识别和验证与原发性结直肠癌相比,肝转移中失调的微小RNA。通过一系列体外和体内试验证明了所选微小RNA的功能意义和潜在分子机制。我们的微阵列分析及随后的定量PCR验证显示,miR-885-5p在肝转移以及源自远处转移的结直肠癌细胞系中强烈上调。miR-885-5p的过表达显著诱导体外细胞迁移、细胞侵袭、应力纤维形成以及体内肝和肺转移的发生。miR-885-5p通过直接结合细胞质聚腺苷酸化元件结合蛋白2的3'非翻译区上的两个结合位点来抑制其转录,从而诱导结直肠癌的转移潜能,进而导致TWIST1上调并因此引发上皮-间质转化。我们的研究结果证明了miR-885-5p在肝转移中的过表达及其在诱导结直肠癌转移中的作用,这为未来开发miR-885-5p抑制剂治疗晚期结直肠癌奠定了基础。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验